期刊文献+

气-质联用法测定人血浆中雷美替胺的浓度和临床应用 被引量:1

Determination of ramelteon in human plasma by gas chromatography-tandem mass spectrometry(GC-MS/MS)and clinic application
原文传递
导出
摘要 目的:建立人血浆中雷美替胺的气相色谱-质谱/质谱联用法(GC-MS/MS)检测方法,为临床药物分析提供依据。方法:血浆样品以乙酸乙酯提取后,经色谱柱BR-5MS毛细管柱(30 m×0.25 mm,0.25μm),程序升温,以多反应监测(MRM)模式进行离子检测。利用保留时间和离子对比例定性,外标法和工作曲线定量,建立人血浆中雷美替胺的GC-MS/MS检测方法。结果:雷美替胺标准曲线范围为1.0~1000.0 ng·mL^-1,定量下限为3.0 ng·mL^-1,日内、日间精密度均小于10%。结论:该方法灵敏准确,简便快速,适用于雷美替胺血药浓度检测。 OBJECTIVE To establish a gas chromatography-mass spectrometry/mass spectrometry(GC-MS/MS)method for the detection of ramelteon in human plasma and provide the basis for clinical drug analysis.METHODS After extraction with ethyl acetate,plasma samples were subjected to column BR-5 MS capillary column(30 m×0.25 mm,0.25μm)with temperature programming and ion detection in multiple reaction monitoring(MRM)mode.The quantitation determination of Remelteon was based on retention time and ration of ions.The quantitative analysis was base on external standard method and calibration curve.RESULTS The linear range of ramelteon was 1.0~1000.0 ng·mL^-1,the lower limit of quantification was 3.0 ng·mL^-1,and the RSD of inter and intra-day were both less than 10%.CONCLUSION The method is sensitive,accurate,simple and rapid,and suitable for the detection of remelton plasma concentration.
作者 王玲 王玉江 周青 孙世芃 孙爱丽 徐水英 赵玉婧 李欣 孙成文 WANG Ling;WANG Yu-jiang;ZHOU Qing;SUN Shi-peng;SUN Ai-li;XU Shui-ying;ZHAO Yu-jing;LI Xin;SUN Cheng-wen(Lab of Toxicant Analysis,the Fifth Medical Center of the People’s Liberation Army General Hospital,Beijing 100071,China;Beijing Fengtai District Center for Disease Control and Prevention,Beijing 100070,China;High-tech Borui Quality Inspection Center,Beijing 100021,China)
出处 《中国医院药学杂志》 CAS 北大核心 2020年第22期2322-2326,共5页 Chinese Journal of Hospital Pharmacy
关键词 雷美替胺 气相色谱-质谱/质谱 血药浓度 Ramelteon gas chromatography-mass spectrometry/mass spectrometry plasma concentration
  • 相关文献

参考文献1

二级参考文献9

  • 1ROTH T,SEIDEN D,ZEE P,et al.phase Ⅲ outpatient trial of ramelteon for the treatment of chronic insomnia in elderly patients[abstract no.A21][J].J Am Geriatr Soc,2005,53 (4 Suppl):S25.
  • 2ZAMMIT G,SCHWARTZ H,ROTH T,et al.Phase Ⅲ study of ramelteon in a first-night-effect model of transient in somnia[abstract no.O007][C]//World association of sleep medicine First Congress.Berlin,Oct 15-18,2005.
  • 3GRIFFITHS RR,SUESS P.Ramelteon (TAK-375) and triazolam in humans:behavioral effects and abuse potential[abstract no.Nr207 plus poster][C]//.158th Annual Meeting of the Amrican Psychiatric Association New Reseach Abstract; Atlanta (GA),2005:76-77.
  • 4HIRAI K,KITA M,OHTA H,et al.Ramelteon(TAK-375)accelerates reentrainment of circadian rhythm after aphase advance of the light-dark cycle in rats[J].J Biol Rhythms,2005,20(1):27-37.
  • 5TURK FW,GILLETTE MU.Melatonin,sleep and circadian rhythms:rationale for development of specific melatonin gonists[J].Sleep Med,2004,5(16):523-532.
  • 6STEVENTSON S,CORNELISSN K,CLARKEE E,et al.Study of the absorption,metabolism,and excretion of(14C) -ramelton (TAK375)[Abstract][J].Clin Pharmacol Ther,2004,75(2):22.
  • 7GREENBLATT DJ,HARMATZ JS.Age and gender effects on the pharmacokinetics of TAK-375[abstract no.0198.C][J].Sleep,2003,26 Abstr(Suppl):A81.
  • 8Takeda Pharmaceuticals America Inc.RozeremTM (ramelteon) tablets:prescribing information (on line)[EB/OL].(2005-08-24).http://www.rozerem.com.
  • 9ERMAN M,SEIDEN D,ZAMMIT G,et al.An efficacy,safety,and dose-response study of ramelteon in patients with chronic primary insomnia[J].Sleep Med,2006,7(1):17-24.

共引文献10

同被引文献18

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部